These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12620078)

  • 21. Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity.
    Abouzid K; Bekhit SA
    Bioorg Med Chem; 2008 May; 16(10):5547-56. PubMed ID: 18430576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
    Tegley CM; Zhi L; Marschke KB; Gottardis MM; Yang Q; Jones TK
    J Med Chem; 1998 Oct; 41(22):4354-9. PubMed ID: 9784110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Buchanan JL; Buckner WH; Cee VJ; Chai L; Deak HL; Epstein LF; Faust T; Gallant P; Geuns-Meyer SD; Gore A; Gu Y; Henkle B; Hodous BL; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; Masse CE; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; White RD; Zhao H; Zhu L; Zhu X
    J Med Chem; 2006 Sep; 49(19):5671-86. PubMed ID: 16970394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selenium-containing heterocycles: synthesis and pharmacological activities of some new 4-methylquinoline-2(1H) selenone derivatives.
    Abdel-Hafez SH; Hussein MA
    Arch Pharm (Weinheim); 2008 Apr; 341(4):240-6. PubMed ID: 18275038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells.
    Dvorák Z; Vrzal R; Maurel P; Ulrichová J
    Chem Biol Interact; 2006 Feb; 159(2):117-28. PubMed ID: 16289013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression.
    Zhao Q; Pang J; Favata MF; Trzaskos JM
    Int Immunopharmacol; 2003 Dec; 3(13-14):1803-17. PubMed ID: 14636830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design.
    Carson MW; Luz JG; Suen C; Montrose C; Zink R; Ruan X; Cheng C; Cole H; Adrian MD; Kohlman DT; Mabry T; Snyder N; Condon B; Maletic M; Clawson D; Pustilnik A; Coghlan MJ
    J Med Chem; 2014 Feb; 57(3):849-60. PubMed ID: 24446728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity.
    Smith CJ; Ali A; Balkovec JM; Graham DW; Hammond ML; Patel GF; Rouen GP; Smith SK; Tata JR; Einstein M; Ge L; Harris GS; Kelly TM; Mazur P; Thompson CM; Wang CF; Williamson JM; Miller DK; Pandit S; Santoro JC; Sitlani A; Yamin TT; O'Neill EA; Zaller DM; Carballo-Jane E; Forrest MJ; Luell S
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2926-31. PubMed ID: 15911283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory activity of the synthetic C-C biflavonoids.
    Park H; Kim YH; Chang HW; Kim HP
    J Pharm Pharmacol; 2006 Dec; 58(12):1661-7. PubMed ID: 17331331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrahydroquinoline glucocorticoid receptor agonists: discovery of a 3-hydroxyl for improving receptor selectivity.
    Roach SL; Higuchi RI; Hudson AR; Adams ME; Syka PM; Mais DE; Miner JN; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2011 Jan; 21(1):168-71. PubMed ID: 21115247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.
    Ray NC; Clark RD; Clark DE; Williams K; Hickin HG; Crackett PH; Dyke HJ; Lockey PM; Wong M; Devos R; White A; Belanoff JK
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4901-5. PubMed ID: 17587578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
    Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
    Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
    J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients.
    Spiliotaki M; Salpeas V; Malitas P; Alevizos V; Moutsatsou P
    Psychoneuroendocrinology; 2006 Jul; 31(6):748-60. PubMed ID: 16621324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
    Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
    J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Kaplita PV; Liu L; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5091-5. PubMed ID: 17681466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of quinolines as selective glucocorticoid receptor agonists.
    Jaroch S; Berger M; Huwe C; Krolikiewicz K; Rehwinkel H; Schäcke H; Schmees N; Skuballa W
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5835-8. PubMed ID: 20727743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
    Liu H; Altenbach RJ; Carr TL; Chandran P; Hsieh GC; Lewis LG; Manelli AM; Milicic I; Marsh KC; Miller TR; Strakhova MI; Vortherms TA; Wakefield BD; Wetter JM; Witte DG; Honore P; Esbenshade TA; Brioni JD; Cowart MD
    J Med Chem; 2008 Nov; 51(22):7094-8. PubMed ID: 18983139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.